Clinical Trials Directory

Trials / Completed

CompletedNCT00219466

Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash

A Parallel, Evaluator-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Two Marketed Topical Skin Protectants Containing Zinc Oxide in Children With Diaper Rash

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide · Industry
Sex
All
Age
2 Months – 36 Months
Healthy volunteers
Accepted

Summary

To evaluate whether Desitin; Zinc Oxide Diaper Rash Ointment (Desitin Original) and Desitin Creamy; Zinc Oxide Diaper Rash Ointment (Desitin Creamy) provide relief of the signs and symptoms associated with diaper rash after 12 and 24 hours of product application.

Detailed description

Subjects received applications of the investigational products following a gentle cleansing of the diaper zone at every diaper change and following bathing of the child during a 24 hour period. Efficacy was assessed during this study through the documentation of the severity of diaper rash. Results of five anatomic areas and overall severity score by the evaluator's assessments, and parent/guardian's assessments all indicated that both products were significantly effective (P\<0.05 in relieving diaper dermatitis (rash) after 12 and 24 hours of treatment. Safety was assessed through the reporting of adverse events during the course of the study. Overall, the reporting of no adverse events under the conditions of the protocol indicate that the investigational products would appear to be safe for their intended use.

Conditions

Interventions

TypeNameDescription
OTHERZinc Oxide Diaper Rash OintmentDesitin Original at diaper change
OTHERAloe Vera/Tocopherol/Zinc Oxide CreamDesitin Creamy at diaper change

Timeline

Start date
2005-06-01
Primary completion
2005-10-01
Completion
2005-10-01
First posted
2005-09-22
Last updated
2011-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00219466. Inclusion in this directory is not an endorsement.